LeonardiAVan SettenGAmraneMet al.Efficacy and safety of 0.1% cyclosporine A cationic emulsion in the treatment of severe dry eye disease: a multicenter randomized trial.Eur J Ophthalmol. 2016;26(4):287–296.
2.
Cationorm® Summary of Product Characteristics.Santen Pharmaceutical Co.
3.
SacchettiMMantelliFLambiaseAMastropasquaAMerloDBoniniSSystematic review of randomised clinical trials on topical ciclosporin A for the treatment of dry eye disease.Br J Ophthalmol. 2014;98(8):1016–1022.
4.
Diaz-LlopisMMenezoJLPenetration of 2% cyclosporin eye drops into human aqueous humour.Br J Ophthalmol. 1989;73(8):600–603.
5.
BaudouinCFigueiredoFCMessmerEMet al.A randomized study of the efficacy and safety of 0.1% cyclosporine A cationic emulsion in treatment of moderate to severe dry eye.Eur J Ophthalmol. 2017;27(5):520–530.
